- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05889936
A Transdiagnostic Intervention for Health-related Habits (LEV)
Research problem and specific questions: Health-related habits influences mental and physical health. Still, screening and treatment of health-related habits, which can help to remedy health problems, is not done at all or very superficially. National guidelines emphasize the importance of prioritizing health-related habits, but there is a lack of implemented models. To solve this, the investigators have developed a transdiagnostic, interprofessional material intended for several care settings.
Study 1: Is LEV a feasible intervention in different healthcare contexts? Study 2: A functional roadmap to healthier habits: A thematic analysis of themes form the functional analysis of unhealthy and healthy lifestyle behavior in adults with disabilities This study will use data from study 1.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Lev is a brief, transdiagnostic, interprofessional intervention targeting health-related habits that is intended for several care settings.This study will therefore be open for participants recruited from several types of healthcare services in Sweden.
Study 1: The feasibility trial investigates the following questions:
- Eligibility to participate - how many of the healthcare workers that had received training in Lev started using it within 6 months? How many participants that were offered Lev agreed to take part in the intervention?
- What were the reasons for not taking part or not completing Lev? Healthcare workers administering Lev will ask the declining participants for reasons to not take part in the intervention.
- How many sessions and homework assignments did the participants complete? Lev includes screening (Lev-s), three sessions and two pre-specified home assignments. The administrating healthcare worker fills in completed sessions and assignments in the case report form. We will set the time limit to 6 months to complete the three sessions including all homework assignments.
Were there any differences between healthcare professions regarding how the applied behavioral analysis was performed (e.g., were there any differences regarding strategies suggested to the participant)?
During session 2, a functional behavioral analysis is performed to generate strategies to help the participant reach their goal. The investigators will conduct a thematic analysis to identify themes for each healthcare profession administrating Lev. This will answer questions regarding if it is possible to conduct this type of analysis in Lev or if further adjustments are needed.
- Level of acceptability: Was Lev perceived as creditable and satisfactory by healthcare workers and participants? Treatment credibility will be measured before Lev and after the last session for both participants and healthcare workers. Treatment satisfaction will be evaluated after each session and after the intervention is completed. Session evaluations will be done by both participants and healthcare workers.
- Was there any part of Lev that was perceived less satisfactory by participants and healthcare workers? A thematic analysis (Braun et al., 2004) will be performed to extract what was perceived as useful and to identify areas of improvement. This will be done both for participants and the healthcare workers.
- Do the intervention lead to adverse events?
- Do Lev lead to healthier habits?
- To what extent were individual goals met?
- Did Lev lead to increased quality of life?
Study 2:
- What general themes underlying unhealthy and healthy habits can be found in individuals with disabilities?
- How do themes vary for specific living habits?
- How do themes vary for specific disabilities?
- How do themes for questions b and c vary depending on sex?
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden, 104 31
- Region Stockholm, Habilitering & Hälsa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Study 1 and 2 will include both adults with and without disabilities recruited from different healthcare contexts.
Exclusion Criteria:
- Intellectual disability of the degree where the participant is not able to follow the protocol in Lev.
- Insufficient command of the Swedish language/ unable to understand the content.
- Severe psychiatric comorbidity that makes participation difficult (e.g. severe depression, severe suicidality, severe anxiety, ongoing psychosis, manic episode), other circumstances that could make participation hard (e.g. homelessness).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Treatment with the Lev-intervention
Screening of health-related habits using Lev-s + a three step/session intervention including the standard Lev protocol.
Typically given over 10-20 weeks.
|
Lev includes three sessions using psychoeducation, motivational interviewing, and applied behavioral analyses.
Lev also include two homework assignments.
The second session can be repeated if needed.
Lev-s and Lev are described in two manuals.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Study 1: Completion rate healthcare workers
Time Frame: 6 month after completing the training.
|
how many of the healthcare workers that had received training in Lev started using it within 6 months
|
6 month after completing the training.
|
|
Study 1: Completion rate participants
Time Frame: 6 month after starting the screening
|
How many of the participants that started using Lev (i.e., completing screening with Lev-s) completed Lev (i.e., completing, 2 out of 3 steps)
|
6 month after starting the screening
|
|
Study 1: Level of treatment credibility healthcare workers
Time Frame: Immediately after the intervention (mean time 20 weeks)
|
Was Lev perceived as creditable and by healthcare workers using Treatment and Credibility Scale.
Four items for credibility and one for expectation on a 10 point Likert scale where higher values indicate higher credibility.
|
Immediately after the intervention (mean time 20 weeks)
|
|
Study 1: Treatment satisfaction healthcare workers (individual sessions)
Time Frame: Immediately after completing session 1. An average of 1-2 months from baseline
|
Treatment satisfaction will be evaluated after session 1 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction.
|
Immediately after completing session 1. An average of 1-2 months from baseline
|
|
Study 1: Treatment satisfaction healthcare workers (individual sessions)
Time Frame: Immediately after completing session 2. An average of 2-4 months from baseline
|
Treatment satisfaction will be evaluated after session 2 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction.
|
Immediately after completing session 2. An average of 2-4 months from baseline
|
|
Study 1: Treatment satisfaction healthcare workers (individual sessions)
Time Frame: Immediately after completing session 3. An average of 4-8 months from baseline
|
Treatment satisfaction will be evaluated after session 3 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction.
|
Immediately after completing session 3. An average of 4-8 months from baseline
|
|
Study 1: Treatment satisfaction participants (individual sessions)
Time Frame: After completing the first module in Lev. An average of 1-2 months from baseline
|
Treatment satisfaction will be evaluated after session 1 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction.
|
After completing the first module in Lev. An average of 1-2 months from baseline
|
|
Study 1: Treatment satisfaction participants (individual sessions)
Time Frame: After completing the second module in Lev. An average of 2-4 month from baseline
|
Treatment satisfaction will be evaluated after session 2 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction.
|
After completing the second module in Lev. An average of 2-4 month from baseline
|
|
Study 1: Treatment satisfaction participants (individual sessions)
Time Frame: After completing the third module in Lev. An average of 4-8 month from baseline
|
Treatment satisfaction will be evaluated after session 3 using a modified version of the Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction.
|
After completing the third module in Lev. An average of 4-8 month from baseline
|
|
Study 1: Open answer questions regarding Treatment satisfaction measured by The Evaluation Questionnaire
Time Frame: Directly after completing the last treatment module in LEV (approximately at 20 weeks).
|
The treatment satisfaction questionnaire also included open questions that will be analyses using a qualitative thematic approach including the following questions:
A qualitative, thematic analysis will be performed to identify more general themes. There is not a template or scale to extract the themes. One rater suggest categories based on the similarity of answers. Another rater organizes the answers in the suggested themes. To be considered a theme, there must be over 85% similarity between raters. |
Directly after completing the last treatment module in LEV (approximately at 20 weeks).
|
|
Study 1: Well-being before and after the intervention measures by The Evaluation Questionnaire
Time Frame: Directly after completing the last treatment module in LEV (approximately at 20 weeks)
|
("How would you rate your well-being prior to the intervention?",
"How would you rate your current well-being") at T1 and T2 on a scale 1-10 (1= very poor, 10= very good)
|
Directly after completing the last treatment module in LEV (approximately at 20 weeks)
|
|
Study 1: Adverse events after the intervention
Time Frame: During the intervention up to week approximately week 20.
|
Adverse events will be defined as spontaneous oral complaints or instances when patients stated that they experienced negative or unwanted effects during the intervention period. Serious adverse events will be defined as events that involved hospital care/hospitalization, etc. due to the intervention. |
During the intervention up to week approximately week 20.
|
|
Study 2: What general themes underlying unhealthy and healthy habits can be found in individuals with disabilities?
Time Frame: During the second step in Lev (Approximately at 5-10 weeks)"
|
Healthcare workers are instructed to enter what strategies they gave to the participant. Strategies from step 2 (page 16 workbook). The themes are extracted based on answers to the following two questions: This is what others can do to help me: ....... I can do this myself:... A qualitative, thematic analysis will be performed to identify more general themes. There is not a template or scale to extract the themes. One rater suggest categories based on the similarity of answers. Another rater organizes the answers in the suggested themes. To be considered a theme, there must be over 85% similarity between raters. |
During the second step in Lev (Approximately at 5-10 weeks)"
|
|
Study 1: Level of treatment credibility participants
Time Frame: Immediately after the intervention (mean time 20 weeks)
|
Was Lev perceived as creditable and by participants using Treatment and Credibility Scale .
Four items for credibility and one for expectation on a 10 point Likert scale where higher values indicate higher credibility.
|
Immediately after the intervention (mean time 20 weeks)
|
|
Study 1: Treatment satisfaction participants (the whole intervention)
Time Frame: Directly after completing the last treatment module in LEV (approximately at 10 weeks)
|
Treatment satisfaction will be evaluated after competing the whole intervention using Patient Evaluation Questionnaire including 5 levels where higher levels indicate higher satisfaction.
The participants also rated the course as a whole following the school grading system ''Failed,'' ''Passed,'' ''Passed with distinction,'' and ''Passed with special |
Directly after completing the last treatment module in LEV (approximately at 10 weeks)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Study 1: Quality of life measured with WHOQOL-BREF.
Time Frame: Before and after taking part in Lev (after is approximately at 10-20 weeks
|
Is Quality of life affected when completing Lev?
The intervention group fill in WHOQOL-BREF at baseline and follow-up.
5 level scale where high levels indicate higher quality of life.
|
Before and after taking part in Lev (after is approximately at 10-20 weeks
|
|
Study 1: Do Lev lead to healthier habits?
Time Frame: Before and after taking part in Lev (after is approximately at 10-20 weeks
|
The Lev-s will be used to measures living habits before and after taking part in Lev.
The scale includes 4 levels where higher levels indicate healthier habits.
|
Before and after taking part in Lev (after is approximately at 10-20 weeks
|
|
Study 1: To what extent were individual goals met?
Time Frame: After completing the whole intervention (approximately at 10-20 weeks
|
During session 1 in the intervention, individual goals are set.
The healthcare worker assesses to what extent the goals have been met using the goal attainment scale.
5 point scale where high vales indicate that goals have been reached to a higher extent.
|
After completing the whole intervention (approximately at 10-20 weeks
|
|
Study 2: How do the themes (e.g., situation, context, behavior, short term gratification) behind unhealthy habits vary for specific living habits?
Time Frame: During the second step in Lev (Approximately at 5-10 weeks)
|
To understand what what underlying behavior and situations that underlies specific unhealthy habits investigators will conduct exploratory qualitative thematic analysis. A qualitative, thematic analysis will be performed to identify more general themes. There is not a template or scale to extract the themes. One rater suggest categories based on the similarity of answers. Another rater organizes the answers in the suggested themes. To be considered a theme, there must be over 85% similarity between raters. |
During the second step in Lev (Approximately at 5-10 weeks)
|
|
Study 2: How do the themes behind unhealthy habits vary for different disabilities?
Time Frame: During the second step in Lev (Approximately at 5-10 weeks)
|
To understand what underlying behavior and situations that underlies unhealthy habits in different groups of disabilities we will conduct exploratory qualitative thematic analysis. A qualitative, thematic analysis will be performed to identify more general themes. There is not a template or scale to extract the themes. One rater suggest categories based on the similarity of answers. Another rater organizes the answers in the suggested themes. To be considered a theme, there must be over 85% similarity between raters. |
During the second step in Lev (Approximately at 5-10 weeks)
|
|
Study 2: How do the themes behind unhealthy habits vary depending on sex?
Time Frame: During the second step in Lev (Approximately at 5-10 weeks)
|
To understand if underlying behavior and situations that underlies unhealthy habits differ depending on sex we will conduct the thematic analysis also separately for sexes. A qualitative, thematic analysis will be performed to identify more general themes. There is not a template or scale to extract the themes. One rater suggest categories based on the similarity of answers. Another rater organizes the answers in the suggested themes. To be considered a theme, there must be over 85% similarity between raters. |
During the second step in Lev (Approximately at 5-10 weeks)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Douglas Sjöwall, PhD, Regions Stockholm
- Study Chair: Joakim Lavesson, Bachelor, Region Stockholm
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- The LEV Project
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Ziekenhuis Oost-LimburgRecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-LifeBelgium
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Istituto Ortopedico RizzoliUniversity of BolognaCompletedImprove Quality of LifeItaly
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
Clinical Trials on Lev
-
Washington University School of MedicineCompletedSubarachnoid HemorrhageUnited States
-
Region StockholmKarolinska Institutet; Promobilia FoundationRecruitingHealth-Related Behavior | Disability Physical | Life Style | Disabilities Mental | Acceptability of Health CareSweden
-
University of AarhusOdense University Hospital; Aarhus University Hospital; Region ZealandNot yet recruitingDiabetes Mellitus, Type 2 | Randomized Controlled TrialDenmark
-
Programme National de Lutte contre l'Onchocercose...CompletedOnchocerciasis, Ocular | LoiasisCongo
-
GlaxoSmithKlineCompletedRhinitis, Allergic, Perennial and SeasonalAustralia
-
UCB Japan Co. Ltd.CompletedEpilepsy | Partial Onset SeizuresJapan
-
Vanderbilt University Medical CenterCompletedSchizophrenia; PsychosisUnited States
-
UCB Japan Co. Ltd.Completed
-
UCB PharmaCompletedEpilepsy, PartialUnited States, France, United Kingdom, Germany, Belgium, Mexico, Poland, India, Romania, South Africa, Canada, Brazil, Russian Federation, Czech Republic, Hungary, Italy
-
Sunnybrook Health Sciences CentreUniversity Health Network, Toronto; Weston Brain InstituteRecruitingHippocampal Hyperactivation | Prodromal Alzheimer DiseaseCanada